Impact of Age on the Efficacy of Immune Checkpoint Inhibitor-Based Combination Therapy for Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Background: Despite the acknowledged benefits of immune checkpoint inhibitor (ICI)-based combination therapy (either with other checkpoint inhibitors, chemotherapy, targeted therapy, or radiotherapy), little is known about the impact of age on the efficacy of ICI -based combination therapy in non-sm...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xin, Tian, Xuan, Wu, Zhiqiang, Han, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538697/
https://www.ncbi.nlm.nih.gov/pubmed/33072551
http://dx.doi.org/10.3389/fonc.2020.01671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538697/
https://www.ncbi.nlm.nih.gov/pubmed/33072551
http://dx.doi.org/10.3389/fonc.2020.01671

Ejemplares similares